04:33 PM EDT, 07/24/2024 (MT Newswires) -- Edwards Lifesciences ( EW ) reported Q2 adjusted earnings Wednesday of $0.70 per diluted share, up from $0.66 a year earlier.

Analysts polled by Capital IQ expected $0.69.

Net sales for the quarter ended June 30 were $1.39 billion, up from $1.30 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.65 billion.

The company said it expects Q3 EPS between $0.67 and $0.71 and sales between $1.56 billion and $1.64 billion.

Analysts polled by Capital IQ expect $0.67 and $1.62 billion, respectively.

Shares dropped over 11% after hours.

Price: 77.01, Change: -9.94, Percent Change: -11.43